Diopsys® NOVA-PERG Nears Launch
PINE BROOK, N.J., Aug. 31, 2012 /PRNewswire/ — Diopsys, Inc. today announced the development and planned launch of the Diopsys(®) NOVA-PERG vision test, an office-based pattern electroretinography (PERG) test for use by eye care professionals. Currently, PERG vision testing is conducted in hospitals and research facilities as a specialized test with results that require interpretation by highly trained doctors. Diopsys has developed an easy-to-use, patient friendly PERG test that gives eye care specialists immediate results in easy-to-read reports.
Diopsys specializes in Visual Evoked Potential (VEP) vision testing devices, so adding PERG technology to its product offerings was a logical step and adds an important new diagnostic tool for the eye care professional. The PERG is an evoked potential test that measures the function of the retina. Patients view a screen with alternating checkerboard patterns to elicit a PERG response. Pattern electroretinography helps doctors gain objective information about the performance of the inner retinal cells of the eye, especially in an area of the retina called the macula. This information can help optometrists and ophthalmologists diagnose and monitor vision disorders like glaucoma, macular degeneration and diabetic retinopathy. One of the reasons PERG is so helpful to doctors is that it assesses the function of the retina. Most other diagnostic tests they may have assess just the retina’s structure or appearance.
“The Diopsys(®) NOVA-PERG is an important addition to the Diopsys(®) NOVA suite of tests. In one sitting, an eye care specialist can objectively measure the function of the patient’s retina while also measuring the function of the entire vision system, from the eye to the visual cortex,” said Dr. Alberto Gonzalez, Diopsys Research Director, “This will help doctors objectively distinguish between retinal and cortical pathway issues.”
This valuable vision testing technology will be available to everyday patients at optometry and ophthalmology offices later this year.
Diopsys, Inc. (www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care solutions. The company specializes in the development and marketing of patient-friendly, non-invasive vision testing devices utilizing Visual Evoked Potential (VEP) technology.
SOURCE Diopsys, Inc.